Maximum Strength-cough And Chest Congestion Dm Capsule, Liquid Filled
NDC Package 53345-034-01
Package Information
Maximum Strength-cough And Chest Congestion Dm capsules is • do not take more than 12 softgels in any 24-hour period• this adult product is not intended for use in children under 12 years of ageagedoseadults and children 12 years and over2 softgels every 4 hourschildren under 12 yearsdo not use. This formulation utilizes a capsule, liquid filled delivery system. Marketed by Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd., this product is identified by NDC 53345-034 and is authorized under FDA application M012.
Identification & Billing
- RxCUI: 1111663 - dextromethorphan HBr 10 MG / guaiFENesin 200 MG Oral Capsule
- RxCUI: 1111663 - dextromethorphan hydrobromide 10 MG / guaifenesin 200 MG Oral Capsule
Clinical Specifications
- Decreased Respiratory Secretion Viscosity - [PE] (Physiologic Effect)
- Expectorant - [EPC] (Established Pharmacologic Class)
- Increased Respiratory Secretions - [PE] (Physiologic Effect)
- Sigma-1 Agonist - [EPC] (Established Pharmacologic Class)
- Sigma-1 Receptor Agonists - [MoA] (Mechanism of Action)
- Uncompetitive N-methyl-D-aspartate Receptor Antagonist - [EPC] (Established Pharmacologic Class)
- Uncompetitive NMDA Receptor Antagonists - [MoA] (Mechanism of Action)
Regulatory & Marketing
Hierarchy Structure
- 53345 - Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd.
- 53345-034 - Maximum Strength-cough And Chest Congestion Dm
- 53345-034-01 - 1 BAG in 1 BOX / 4000 CAPSULE, LIQUID FILLED in 1 BAG
- 53345-034 - Maximum Strength-cough And Chest Congestion Dm
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 53345-034-01 identifies a specific commercial package of 1 bag in 1 box / 4000 capsule, liquid filled in 1 bag of Maximum Strength-cough And Chest Congestion Dm, a human over the counter drug labeled by Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd.. This capsule, liquid filled is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd. on June 30, 2015. The current certification is valid through December 31, 2026.
How is this Humanwell Puracap Pharmaceutical (wuhan) Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 53345003401. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.